Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.460
0.00 (0.00%)
Oct 31, 2025, 10:35 AM EDT - Market open

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $108.79 million as of October 31, 2025. Its market cap has increased by 616.26% in one year.

Market Cap
108.79M
Enterprise Value
21.17M
1-Year Change
616.26%
Ranking
Category
Stock Price
$1.46

Market Cap Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $108.79M, an increase of 8.30%. That is a compound annual growth rate of 1.66%.

History

DateMarket Cap% Change
Oct 30, 2025108.79M-50.18%
Dec 31, 2024218.38M2,684.93%
Dec 29, 20237.84M-37.83%
Dec 30, 202212.61M-65.89%
Dec 31, 202136.98M-46.68%
Dec 31, 202069.35M-30.96%
Dec 23, 2020100.46M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition